Kenmore, NY, United States of America

Robert G Hughes, Jr

This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert G Hughes, Jr. Retrieved from https://idiyas.com/inventor/robert-g-hughes-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert G Hughes, Jr.

Introduction

Robert G Hughes, Jr. is a notable inventor based in Kenmore, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polynucleotide analogs. His work has implications for cancer treatment and therapeutic applications.

Latest Patents

Hughes holds a patent for "Novel polynucleotide analogs, methods for inhibiting nucleic acid." This patent describes polyribonucleotide analogs that are partially substituted by the introduction of mercapto groups and fluorine at the 5-position of some of their cytosine and uracil bases. These analogs exhibit effective in vivo antitumor activity. Additionally, double-stranded complexes formed from such polynucleotides are especially active as interferon inducers. He has 1 patent to his name.

Career Highlights

Hughes is affiliated with The State University of New York, where he continues to engage in research and development. His work is characterized by a commitment to advancing scientific knowledge and practical applications in medicine.

Collaborations

Some of his notable coworkers include Yau-Kwan Ho and Steven J Kasper. Their collaborative efforts contribute to the innovative research environment at the university.

Conclusion

Robert G Hughes, Jr. exemplifies the spirit of innovation in biotechnology through his groundbreaking work on polynucleotide analogs. His contributions have the potential to impact cancer treatment significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…